Alexion Pharmaceuticals

Alexion Pharmaceuticals

Alexion Pharmaceuticals, Inc (NASDAQ: ALXN) | World Leader in Treatments for Patients with Devastating and Rare Diseases.

Launch date
Employees
Market cap
-
Enterprise valuation
$39.0b (Public information from Dec 2020)
Boston Massachusetts (HQ)
Authorizing premium user...